Piper Continues to Recommend Biogen Shares After Deeper Dive on BIIB067
March 26, 2019 at 07:18 AM EDT
Piper Jaffray analyst Christopher Raymond continues to recommend Biogen shares after a deeper dive on BIIB067, an antisense oligonucleotide targeting SOD1 for the treatment of SOD1-amyotrophic lateral sclerosis. W
